Koninklijke Philips N.V. (PHG)
USD 24.71
(-1.2%)
USD 24.71
(-1.2%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 6.95 Billion EUR | -4.28% |
| 2022 | 7.27 Billion EUR | 12.31% |
| 2021 | 6.47 Billion EUR | 13.46% |
| 2020 | 5.7 Billion EUR | 15.51% |
| 2019 | 4.93 Billion EUR | 44.12% |
| 2018 | 3.42 Billion EUR | -15.26% |
| 2017 | 4.04 Billion EUR | 0.57% |
| 2016 | 4.02 Billion EUR | -1.81% |
| 2015 | 4.09 Billion EUR | 10.32% |
| 2014 | 3.71 Billion EUR | 12.18% |
| 2013 | 3.3 Billion EUR | -11.17% |
| 2012 | 3.72 Billion EUR | 13.64% |
| 2011 | 3.27 Billion EUR | 16.32% |
| 2010 | 2.81 Billion EUR | -22.58% |
| 2009 | 3.64 Billion EUR | 5.02% |
| 2008 | 3.46 Billion EUR | 185.5% |
| 2007 | 1.21 Billion EUR | -59.61% |
| 2006 | 3 Billion EUR | -9.39% |
| 2005 | 3.31 Billion EUR | -6.55% |
| 2004 | 3.54 Billion EUR | -15.17% |
| 2003 | 4.18 Billion EUR | -35.61% |
| 2002 | 6.49 Billion EUR | -1.64% |
| 2001 | 6.6 Billion EUR | 188.45% |
| 2000 | 2.29 Billion EUR | -16.56% |
| 1999 | 2.74 Billion EUR | -0.92% |
| 1998 | 2.77 Billion EUR | -15.7% |
| 1997 | 3.28 Billion EUR | -8.5% |
| 1996 | 3.59 Billion EUR | 12.75% |
| 1995 | 3.18 Billion EUR | -44.34% |
| 1994 | 5.72 Billion EUR | -6.06% |
| 1993 | 6.09 Billion EUR | -12.59% |
| 1992 | 6.96 Billion EUR | 41.0% |
| 1991 | 4.94 Billion EUR | -3.94% |
| 1990 | 5.14 Billion EUR | 16.1% |
| 1989 | 4.43 Billion EUR | 2.88% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 7.13 Billion EUR | 0.0% |
| 2024 Q1 | - EUR | -100.0% |
| 2024 Q3 | - EUR | -100.0% |
| 2023 Q3 | - EUR | -100.0% |
| 2023 Q4 | 6.95 Billion EUR | 0.0% |
| 2023 Q2 | 7.17 Billion EUR | -53.14% |
| 2023 Q1 | 15.31 Billion USD | 110.67% |
| 2023 FY | 6.95 Billion EUR | -4.28% |
| 2022 Q2 | 6.78 Billion EUR | 0.0% |
| 2022 Q4 | 7.27 Billion EUR | 0.0% |
| 2022 FY | 7.27 Billion EUR | 12.31% |
| 2022 Q3 | - EUR | -100.0% |
| 2022 Q1 | - EUR | -100.0% |
| 2021 Q2 | 5.88 Billion EUR | 0.0% |
| 2021 Q4 | 6.47 Billion EUR | 0.0% |
| 2021 FY | 6.47 Billion EUR | 13.46% |
| 2021 Q1 | - EUR | -100.0% |
| 2021 Q3 | - EUR | -100.0% |
| 2020 Q2 | 6.7 Billion EUR | 0.0% |
| 2020 Q4 | 5.7 Billion EUR | 0.0% |
| 2020 Q1 | - EUR | -100.0% |
| 2020 FY | 5.7 Billion EUR | 15.51% |
| 2020 Q3 | - EUR | -100.0% |
| 2019 Q4 | 4.93 Billion EUR | 0.0% |
| 2019 Q1 | - EUR | -100.0% |
| 2019 Q2 | 4.78 Billion EUR | 0.0% |
| 2019 Q3 | - EUR | -100.0% |
| 2019 FY | 4.93 Billion EUR | 44.12% |
| 2018 Q2 | 3.68 Billion EUR | 0.0% |
| 2018 Q1 | - EUR | -100.0% |
| 2018 Q4 | 3.42 Billion EUR | 0.0% |
| 2018 Q3 | - EUR | -100.0% |
| 2018 FY | 3.42 Billion EUR | -15.26% |
| 2017 Q4 | 4.04 Billion EUR | -8.94% |
| 2017 FY | 4.04 Billion EUR | 0.57% |
| 2017 Q1 | 3.96 Billion EUR | -1.29% |
| 2017 Q2 | 2.59 Billion EUR | -34.52% |
| 2017 Q3 | 4.44 Billion EUR | 70.87% |
| 2016 Q3 | 4.86 Billion EUR | -7.76% |
| 2016 Q1 | 3.98 Billion EUR | -2.71% |
| 2016 Q2 | 5.26 Billion EUR | 32.25% |
| 2016 Q4 | 4.02 Billion EUR | -17.26% |
| 2016 FY | 4.02 Billion EUR | -1.81% |
| 2015 Q3 | 3.97 Billion EUR | -1.85% |
| 2015 Q1 | 4.11 Billion EUR | 10.94% |
| 2015 Q4 | 4.09 Billion EUR | 3.07% |
| 2015 FY | 4.09 Billion EUR | 10.32% |
| 2015 Q2 | 4.04 Billion EUR | -1.7% |
| 2014 Q1 | 3.31 Billion EUR | 0.06% |
| 2014 Q4 | 3.71 Billion EUR | 3.57% |
| 2014 Q3 | 3.58 Billion EUR | 7.43% |
| 2014 Q2 | 3.33 Billion EUR | 0.76% |
| 2014 FY | 3.71 Billion EUR | 12.18% |
| 2013 Q1 | 3.56 Billion EUR | -4.43% |
| 2013 FY | 3.3 Billion EUR | -11.17% |
| 2013 Q2 | 3.5 Billion EUR | -1.66% |
| 2013 Q4 | 3.3 Billion EUR | -1.93% |
| 2013 Q3 | 3.37 Billion EUR | -3.63% |
| 2012 Q1 | 3.97 Billion EUR | 21.26% |
| 2012 Q2 | 4.12 Billion EUR | 3.72% |
| 2012 FY | 3.72 Billion EUR | 13.64% |
| 2012 Q4 | 3.72 Billion EUR | -2.92% |
| 2012 Q3 | 3.83 Billion EUR | -6.94% |
| 2011 Q1 | 2.67 Billion EUR | -5.07% |
| 2011 FY | 3.27 Billion EUR | 16.32% |
| 2011 Q3 | 2.93 Billion EUR | 8.4% |
| 2011 Q4 | 3.27 Billion EUR | 11.88% |
| 2011 Q2 | 2.7 Billion EUR | 1.05% |
| 2010 Q2 | 3.05 Billion EUR | -13.83% |
| 2010 FY | 2.81 Billion EUR | -22.58% |
| 2010 Q1 | 3.54 Billion EUR | -2.66% |
| 2010 Q4 | 2.81 Billion EUR | 1.44% |
| 2010 Q3 | 2.77 Billion EUR | -9.01% |
| 2009 Q3 | 3.59 Billion EUR | -3.93% |
| 2009 Q4 | 3.64 Billion EUR | 1.17% |
| 2009 Q2 | 3.74 Billion EUR | -2.09% |
| 2009 Q1 | 3.82 Billion EUR | 11.16% |
| 2009 FY | 3.64 Billion EUR | 5.02% |
| 2008 Q2 | 3.15 Billion EUR | -0.45% |
| 2008 FY | 3.46 Billion EUR | 185.5% |
| 2008 Q1 | 3.16 Billion EUR | 161.05% |
| 2008 Q3 | 3.29 Billion EUR | 4.42% |
| 2008 Q4 | 3.44 Billion EUR | 4.44% |
| 2007 Q4 | 1.21 Billion EUR | -67.72% |
| 2007 Q3 | 3.76 Billion EUR | 182.15% |
| 2007 FY | 1.21 Billion EUR | -59.61% |
| 2007 Q1 | 2.92 Billion EUR | -2.65% |
| 2007 Q2 | 1.33 Billion EUR | -54.45% |
| 2006 Q4 | 3 Billion EUR | -1.0% |
| 2006 Q3 | 3.03 Billion EUR | -4.8% |
| 2006 Q1 | 3.23 Billion EUR | -2.39% |
| 2006 FY | 3 Billion EUR | -9.39% |
| 2006 Q2 | 3.18 Billion EUR | -1.52% |
| 2005 Q1 | 3.6 Billion EUR | 1.6% |
| 2005 FY | 3.31 Billion EUR | -6.55% |
| 2005 Q4 | 3.31 Billion EUR | -1.65% |
| 2005 Q3 | 3.37 Billion EUR | -7.42% |
| 2005 Q2 | 3.64 Billion EUR | 1.02% |
| 2004 Q4 | 3.54 Billion EUR | -7.54% |
| 2004 FY | 3.54 Billion EUR | -15.17% |
| 2004 Q1 | 4.31 Billion EUR | 3.09% |
| 2004 Q2 | 4.2 Billion EUR | -2.51% |
| 2004 Q3 | 3.83 Billion EUR | -8.72% |
| 2003 Q4 | 4.18 Billion EUR | -5.12% |
| 2003 FY | 4.18 Billion EUR | -35.61% |
| 2003 Q3 | 4.41 Billion EUR | -14.77% |
| 2003 Q2 | 5.17 Billion EUR | -18.33% |
| 2003 Q1 | 6.33 Billion EUR | -2.49% |
| 2002 FY | 6.49 Billion EUR | -1.64% |
| 2002 Q1 | 7.98 Billion EUR | 20.94% |
| 2002 Q2 | 7.79 Billion EUR | -2.45% |
| 2002 Q3 | 11.24 Billion EUR | 44.32% |
| 2002 Q4 | 6.49 Billion EUR | -42.23% |
| 2001 FY | 6.6 Billion EUR | 188.45% |
| 2001 Q2 | 6.21 Billion EUR | 15.17% |
| 2001 Q1 | 5.39 Billion EUR | 135.66% |
| 2001 Q3 | 8.25 Billion EUR | 32.82% |
| 2001 Q4 | 6.6 Billion EUR | -19.98% |
| 2000 Q1 | 3.28 Billion EUR | 19.81% |
| 2000 FY | 2.29 Billion EUR | -16.56% |
| 2000 Q2 | 3.43 Billion EUR | 4.45% |
| 2000 Q3 | 3.5 Billion EUR | 2.18% |
| 2000 Q4 | 2.29 Billion EUR | -34.75% |
| 1999 FY | 2.74 Billion EUR | -0.92% |
| 1999 Q2 | 3.48 Billion EUR | 0.6% |
| 1999 Q1 | 3.46 Billion EUR | 24.91% |
| 1999 Q3 | 3.36 Billion EUR | -3.22% |
| 1999 Q4 | 2.74 Billion EUR | -18.52% |
| 1998 Q1 | 3.18 Billion EUR | -3.06% |
| 1998 FY | 2.77 Billion EUR | -15.7% |
| 1998 Q4 | 2.77 Billion EUR | -2.54% |
| 1998 Q3 | 2.84 Billion EUR | -4.29% |
| 1998 Q2 | 2.96 Billion EUR | -6.77% |
| 1997 Q1 | 5.9 Billion EUR | 64.44% |
| 1997 FY | 3.28 Billion EUR | -8.5% |
| 1997 Q4 | 3.28 Billion EUR | -40.86% |
| 1997 Q3 | 5.55 Billion EUR | -9.9% |
| 1997 Q2 | 6.16 Billion EUR | 4.43% |
| 1996 Q4 | 3.59 Billion EUR | 0.0% |
| 1996 FY | 3.59 Billion EUR | 12.75% |
| 1995 FY | 3.18 Billion EUR | -44.34% |
| 1995 Q4 | 3.18 Billion EUR | 0.0% |
| 1994 Q4 | 5.72 Billion EUR | 0.0% |
| 1994 FY | 5.72 Billion EUR | -6.06% |
| 1993 Q4 | 6.09 Billion EUR | 0.0% |
| 1993 FY | 6.09 Billion EUR | -12.59% |
| 1992 Q4 | 6.96 Billion EUR | 0.0% |
| 1992 FY | 6.96 Billion EUR | 41.0% |
| 1991 FY | 4.94 Billion EUR | -3.94% |
| 1991 Q4 | 4.94 Billion EUR | 0.0% |
| 1990 Q4 | 5.14 Billion EUR | 0.0% |
| 1990 FY | 5.14 Billion EUR | 16.1% |
| 1989 Q4 | 4.43 Billion EUR | 0.0% |
| 1989 FY | 4.43 Billion EUR | 2.88% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Abbott Laboratories | 13.59 Billion USD | 48.827% |
| Allurion Technologies Inc. | 2.3 Million USD | -301677.971% |
| Artivion, Inc. | 305.53 Million USD | -2177.674% |
| Avanos Medical, Inc. | 159.4 Million USD | -4265.747% |
| Butterfly Network, Inc. | 22.83 Million USD | -30375.148% |
| Butterfly Network, Inc. | 22.83 Million USD | -30375.148% |
| Bio-Rad Laboratories, Inc. | 1.18 Billion USD | -485.059% |
| Boston Scientific Corporation | 8.96 Billion USD | 22.341% |
| Perspective Therapeutics, Inc. | - USD | -Infinity% |
| CONMED Corporation | 971.48 Million USD | -616.328% |
| Edwards Lifesciences Corporation | 670 Million USD | -938.657% |
| Paragon 28, Inc. | 109.79 Million USD | -6237.945% |
| Glaukos Corporation | 383.73 Million USD | -1713.477% |
| Globus Medical, Inc. | 417.4 Million USD | -1567.226% |
| Inspire Medical Systems, Inc. | 24.84 Million USD | -27908.533% |
| Integer Holdings Corporation | 959.92 Million USD | -624.952% |
| Medtronic plc | 23.87 Billion USD | 70.855% |
| Nevro Corp. | 211.47 Million USD | -3190.759% |
| Owlet, Inc. | 22 Thousand USD | -31631718.182% |
| Penumbra, Inc. | 220.9 Million USD | -3050.166% |
| Vicarious Surgical Inc. | 13.78 Million USD | -50382.408% |
| Smith & Nephew plc | 2.17 Billion USD | -219.954% |
| Sonendo, Inc. | 14.03 Million USD | -49483.185% |
| STERIS plc | 3.12 Billion USD | -123.033% |
| Stryker Corporation | 10.9 Billion USD | 36.162% |
| Vapotherm, Inc. | 109.97 Million USD | -6227.629% |
| Zimmer Biomet Holdings, Inc. | 4.86 Billion USD | -42.957% |